Cytokine mRNA Expression in Pneumococcal Carriage, Pneumonia, and Sepsis in Young Mice

Journal of Infectious Diseases

Volumn 188, Issue 11, 2003, Pages 1752-1756

  Ling, Eduard ^a   Feldman, Galia ^a   Dagan, Ron ^a   Mizrachi Nebenzahl, Yaffa ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; IMMUNE SYSTEM; INBRED STRAIN; LUNG; MALE; MORTALITY; MOUSE; NASOPHARYNX; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTEREMIA; CARRIER STATE; CYTOKINES; INTERLEUKIN-12; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NASOPHARYNX; PNEUMONIA, PNEUMOCOCCAL; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347517723     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/379371     Document Type: Article

References (15)

1. Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JL. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996; 174:752-9.
2. Diamond Gill, Legarda D, Ryan LK. The innate response of the respiratory epithelium. Immunol Rev 2000; 173:27-38.
3. Mosmann TB, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
4. Ulett G, Ketheesan N, Hirst R. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun 2000; 68:2034-42.
5. Siegrist C-A. Neonatal and early life vaccinology. Vaccine 2001; 19:3331-46.
6. Wu H-Y, Virolainen A, Mathews B, King J, Russel MW, Briles DE. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog 1997; 23:127-37.
7. Saeland E, Vidarsson G, Jonsdottir I. Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies. Microb Pathog 2000; 29:81-91.
8. Jarva H, Janulczuk R, Hellwage J, Zipfel PF, Bjorck L, Meri S. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol 2002; 168:1886-95.
9. Vandevoorde V, Haegeman G, Fiers W. Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects. J Cell Biol 1997; 137:1627-38.
10. Khan AQ, Shen Yi, Wu Z-Q, Wynn TA, Snapper CM. Endogeneous pro-and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect Immun 2002; 70:749-61.
11. Letterio JJ. Murine models define the role of TGF-β as a master regulator of immune cell function. Cytokine Growth Factor Rev 2000; 11:81-7.
12. Nakao A, Miike S, Hatano M, et al. Blockage of transforming growth factor β/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med 2000; 192:151-8.
13. Li YH, Brauner A, Jonsson B, et al. Inhibition of macrophage proinflammatory cytokine expression by steroids and recombinant IL10. Biol Neonate 2001; 80:124-32.
14. Samson LM, Allen UD, Greery WD, Diaz-Mitoma F, Singh RN. Elevated interleukin-1 receptor antagonist levels in pediatric sepsis syndrome. J Pediatr 1997; 131:587-91.
15. Schumann RR, Pfeil D, Freyer D, et al. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia 1998; 22:295-305.